510(k) Report

510(k) · Cleared

Cleared

OsteoSelect PLUS Demineralized Bone Matrix Putty

K150621510(k) TraditionalCleared Aug 18, 2015160-day reviewClass II21 CFR 888.3045

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bacterin International, Inc. · MQV Filler, Bone Void, Calcium Compound

Cleared on Aug 18, 2015 as substantially equivalent to K091321 (Bacterin International, Inc., 2009) and 1 other predicate after a 160-day review. Its family tree reaches back 3 generations to 2005.

Decided
Aug 18, 2015
Review
160 days
Class
Class II
Product code
MQV
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K040262 (2005). 6 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 3 generations backK040262 DBX Demineralized Bone Matrix Putty, Bone Matrix Paste and Bone…Musculoskeletal Transplant Foundation · 2005 · Recalled
  2. 2 generations backK091321 Osteoselect Demineralized Bone Matrix PuttyBacterin International, Inc. · 2009 · Recalled
  3. 1 generation backK130498 Osteoselect Demineralized Bone Matrix PuttyBacterin International, Inc. · 2013 · Recalled
  4. This deviceK150621 OsteoSelect PLUS Demineralized Bone Matrix PuttyBacterin International, Inc. · 2015
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K040262DBX Demineralized Bone Matrix Putty, Bone Matrix Paste and Bone Matrix MixMusculoskeletal Transplant Foundation20052
−2K091321Osteoselect Demineralized Bone Matrix PuttyBacterin International, Inc.20092
−1K130498Osteoselect Demineralized Bone Matrix PuttyBacterin International, Inc.20131
0 (this device)K150621OsteoSelect PLUS Demineralized Bone Matrix PuttyBacterin International, Inc.2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200510
201120
FIG. 1 — Lineage of K150621, 2005–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MQV device

  1. #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K091321Osteoselect Demineralized Bone Matrix Putty
Summary page 5
…icate Devices Primary Predicate OsteoSelect® Demineralized Bone Matrix Putty Bacterin International, Inc. K091321 (use in extremities and pelvis) K130498 (use in posterolateral spine) References DBX®…
Bacterin International, Inc.20092
*K130498Osteoselect Demineralized Bone Matrix Putty
Summary page 5
…d Bone Matrix Putty Bacterin International, Inc. K091321 (use in extremities and pelvis) K130498 (use in posterolateral spine) References DBX® MIX Demineralized Bone Matrix Putty Muscu…
Bacterin International, Inc.20131
†K063676DBX Demineralized Bone Matrix MixMusculoskeletal Transplant Foundation2007—
†K082002Progenix PlusMedtronic Sofamor Danek2008—

Also cleared against K091321: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 10 years and passes through 2 companies; a new generation was cleared every 3.7 years on median.
  • 4 of the 6 ancestors have a recall of any class.
  • 1 other device also cites its predicate K091321.

How does its category compare?

All MQV devices

MQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · MQV

14in 2025

2007: 352008: 322009: 232010: 172011: 162012: 92013: 122014: 202015: 182016: 82017: 172018: 232019: 132020: 152021: 82022: 92023: 212024: 282025: 142026 (partial year): 5
2007high 35 (2007) · low 8 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MQV

57in 2025

2007: 144 days median2008: 102 days median2009: 180 days median2010: 147 days median2011: 92 days median2012: 107 days median2013: 197 days median2014: 153 days median2015: 184 days median2016: 214 days median2017: 124 days median2018: 124 days median2019: 90 days median2020: 132 days median2021: 88 days median2022: 118 days median2023: 74 days median2024: 55 days median2025: 57 days median2026 (partial year): 96 days median
2007high 214 (2016) · low 55 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MQV

1in 2025

2007: 52008: 32009: 12011: 62012: 32013: 22016: 12017: 12018: 22020: 12023: 32024: 22025: 12026 (partial year): 4
2007high 6 (2011) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MQV

57in 2025

2007: 672008: 712009: 812010: 682011: 1142012: 1492013: 2232014: 1112015: 1252016: 1062017: 1072018: 862019: 652020: 1262021: 1012022: 472023: 1202024: 682025: 57
2007high 223 (2013) · low 47 (2022)2025

MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735144567
200832102371
200923180181
201017147068
201116926114
201291073149
2013121972223
2014201530111
2015181840125
201682141106
2017171241107
201823124286
20191390065
2020151321126
20218880101
20229118047
202321743120
20242855268
20251457157
20265964—

What is it indicated for?

OsteoSelect® (DBM) Putty is indicated for use as a bone void filler and bone graft substitute for voids or gaps that are not intrinsic to the stability of the bony structure. OsteoSelect® (DBM) Putty is indicated for treatment of surgically created osseous defects or osseous defects from traumatic injury to the bone.

OsteoSelect® (DBM) Putty can be used as follows:

* Extremities

* Posterolateral spine

* Pelvis

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K150621: OsteoSelect PLUS Demineralized Bone Matrix Putty.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K150621

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026